POLICY | AACR Releases Landmark Cancer Progress Report The American Association for Cancer Research (AACR) unveiled the AACR Cancer Progress Report 2011 during a press conference at the National Press Club in Washington, D.C. [American Association for Cancer Research] Press Release Texas Prepares to Fight for Stem Cells Although scientists and physicians in Texas are excited about the funding to develop stem-cell science, many are concerned that treatments will reach the clinic before safety and efficacy are properly established. [Texas Republican Party, United States] Press Release Stem Cell Lawsuit Back Again As expected, the plaintiffs in a law suit claiming that federally funded research on human embryonic stem cells is illegal have appealed a ruling that dealt them a defeat earlier this summer. [U.S. Appeals Court, United States] Press Release Governor Quinn Announces Agreement to Enhance Illinois’ Biotech Industry During his economic and business trade mission throughout China, Governor Pat Quinn announced the signing of a memorandum of cooperation between the Illinois Science & Technology Coalition, iBIO, and China-based Shanghai Bio Pharmaceutics Association to increase economic opportunities for both regions in the bio-technology field. [Illinois Science & Technology Coalition, United States] Press Release Austria Reinstates Disgraced Doctor The Medical University of Innsbruck suspended Hannes Strasser three years ago after serious concerns were first raised about his trial of a novel stem-cell therapy for urinary incontinence. But on 8 September the Vienna-based National Disciplinary Committee revoked Strasser’s suspension. [National Disciplinary Committee, Austria] Press Release | BUSINESS | Universities and Science Minister to Launch Research Collaboration The Minister of State for Universities and Science, David Willetts, officially launched a new phase in an innovative partnership between the North of England´s eight research intensive universities. [The University of Sheffield] Press Release Mayo Clinic Enters Collaboration That Takes Aim at Lou Gehrig’s Disease Mayo Clinic’s campus in Florida has entered into a collaborative and sponsored research agreement with SK Biopharmaceuticals, with the goal of developing new treatments for amyotrophic lateral sclerosis. [Mayo Clinic] Press Release Three U-M Researchers Named 2011 MacArthur Fellows Three University of Michigan (U-M) researchers are among the 22 new MacArthur Fellows announced by the John D. and Catherine T. MacArthur Foundation. [University of Michigan Health System] Press Release
Stem Cell Signaling: Transformative NIH Grant will Support Development of Tissue Regeneration Therapeutics for Traumatic Injuries The National Institutes of Health (NIH) has awarded nearly $2 million to researchers at the Georgia Institute of Technology and Emory University to develop a new class of therapeutics for treating traumatic injuries and degenerative diseases. [Georgia Institute of Technology] Press Release AGTC Receives Grant from the Foundation Fighting Blindness for Pre-Clinical Study of Gene Therapy for Eye Disease Applied Genetic Technologies Corporation (AGTC) announces that it has received a grant of $1.5 million from the Foundation Fighting Blindness to fund a pre-clinical trial evaluating the safety and efficacy of a gene therapy treatment for X-linked Retinoschisis. [Applied Genetic Technologies Corporation] Press Release
Penn Vet Professor Gustavo D. Aguirre Receives Grant from Foundation Fighting Blindness Foundation Fighting Blindness has awarded Penn Vet Professor of Medical Genetics and Ophthalmology Gustavo D. Aguirre with a $230,000 grant to continue the Penn Translational and Research Facility. [University of Pennsylvania] Press Release Three UC Davis Researchers Win Prestigious NIH Awards The National Institutes of Health (NIH) named three University of California (UC) Davis researchers recipients of highly competitive awards designed to encourage innovative, high-risk research and accelerate the translation of science into improved health. [University of California, Davis] Press Release
New Trial for Retinal Stem Cell Treatment Gets Go-Ahead at Moorfields Eye Hospital Trials of an experimental new treatment that could offer hope to young people suffering from a currently untreatable inherited eye condition will get underway soon at Moorfields Eye Hospital following approval by the Medicines and Healthcare Products Regulatory Agency. [Moorfields Eye Hospital] Press Release
ACT Receives Approval for First Human Embryonic Stem Cell Trial in Europe Advanced Cell Technology, Inc. announced that it has received clearance from the U.K. Medicines and Healthcare products Regulatory Agency to begin treating patients as part of a Phase I/II clinical trial for Stargardt’s Macular Dystrophy using retinal pigment epithelium derived from human embryonic stem cells. [Advanced Cell Technology, Inc] Press Release Embryonic Stem Cell Therapy for Paralysis Given to First Patient in Western United States The Stanford University School of Medicine and Santa Clara Valley Medical Center have enrolled the fourth participant in the nation’s first trial of cells derived from human embryonic stem cells. [Stanford School of Medicine] Press Release
Stratatech Initiates Second Clinical Trial of StrataGraft® Skin Substitute Stratatech Corp. announced that it has initiated its second multicenter clinical trial of the company’s StrataGraft® skin substitute. [Stratatech Corporation] Press Release
Cedars-Sinai Opens New Induced Pluripotent Stem Cell Core Production Facility The Cedars-Sinai Regenerative Medicine Institute has opened a new Induced Pluripotent Stem Cell Core Facility to produce powerful cells capable of making all tissues of the body from adult human skin cells. [Cedars-Sinai Medical Center] Press Release SanBio Announces Site Opening of Phase I/IIa Clinical Trial of Novel Cell Therapy in Stable Stroke Patients at University of Pittsburgh Medical Center SanBio, Inc. announced the site initiation and opening of a Phase I/IIa clinical trial testing a novel cell therapy product, SB623, in patients suffering from disability resulting from ischemic stroke. [PR Newswire] Press Release | CBER | September 20, 2011: Vaccines and Related Biological Products Advisory Committee Meeting Public Roster
September 20, 2011: Vaccines and Related Biological Products Advisory Committee Meeting Agenda
September 22, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting Materials
September 22, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting Final Agenda
September 23, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting Materials
September 23, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting Final Agenda | |
|
|